|
|
||||||||
4β1- and
5β1-Mediated Adhesion and Proliferation of CD34+ Hematopoietic Progenitor Cells1
* Department of Medicine II, University of Tübingen, Tübingen, Germany; and
Department of Medicine III, Marienhospital, Stuttgart, Germany
Cytokines and chemokines control hematopoietic stem and progenitor cell (HPC) proliferation and trafficking. However, the role of nonpeptide mediators in the bone marrow microenvironment has remained elusive. Particularly CysLT1, a G protein-coupled receptor recognizing inflammatory mediators of the cysteinyl leukotriene family, is highly expressed in HPCs. We therefore analyzed the effects of its ligands on human CD34+ HPCs. The most potent CysLT1 ligand, LTD4, rapidly and significantly up-regulated
4β1 and
5β1 integrin-dependent adhesion of both primitive and committed HPC. LTD4-triggered adhesion was inhibited by specific CysLT1 antagonists. The effects of other CysLT1 ligands were weak (LTC4) or absent (LTE4). In serum-free liquid cultures supplemented with various hematopoietic cytokines including IL-3, only LTD4 significantly augmented the expansion of HPCs in a dose-dependent manner comparable to that of peptide growth factors. LTC4 and LTE4 were less effective. In CD34+ cell lines and primary HPCs, LTD4 induced phosphorylation of p44/42 ERK/MAPK and focal adhesion kinase-related tyrosine kinase Pyk2, which is linked to integrin activation. Bone marrow stromal cells produced biologically significant amounts of cysteinyl leukotrienes only when hematopoietic cells were absent, suggesting a regulatory feedback mechanism in the hematopoietic microenvironment. In contrast to antagonists of the homing-related G protein-coupled receptor CXCR4, administration of a CysLT1 antagonist failed to induce human CD34+ HPC mobilization in vivo. Our results suggest that cysteinyl leukotriene may contribute to HPC retention and proliferation only when cysteinyl leukotriene levels are increased either systemically during inflammation or locally during marrow aplasia.
The costs of publication of this article were defrayed in part by the payment of page charges. This article must therefore be hereby marked advertisement in accordance with 18 U.S.C. Section 1734 solely to indicate this fact.
1 This work was supported by Deutsche Forschungsgemeinschaft Grant SFB 510/A4 and Deutsche José Carreras Leukämiestiftung Grants DJCLS R04/13 and R08/24v.
2 Address correspondence and reprint requests to Dr. Robert Möhle, Department of Medicine II, University of Tübingen, Otfried-Müller-Strasse 10, 72076 Tübingen, Germany. E-mail address: robert.moehle{at}med.uni-tuebingen.de
3 Abbreviations used in this paper: HPC, hematopoietic stem and progenitor cell; BMEC, bone marrow endothelial cell; CAFC, cobblestone area-forming cell; EIA, enzyme immunoassay; GPCR, G protein-coupled receptor; 5-LO, 5-lipoxygenase; LT, leukotriene; MPA, mycophenolic acid; PTX, pertussis toxin; rh, recombinant human; SDF, stromal cell-derived factor.
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |